Screening for Pancreatic Cancer: Current Status and Future Directions
Pancreatic ductal adenocarcinoma is a lethal disease for a multitude of reasons, including difficulty of early detection, early metastatic spread, and absence of more effective therapies. Even with the advent of newer systemic therapies, the 1-year survival for metastatic disease ranges from 17–23%...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2017-11-01
|
| Series: | European Medical Journal |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/oncology/article/editors-pick-screening-for-pancreatic-cancer-current-status-and-future-directions/ |